Flomics has officially signed a collaboration agreement with M20 Genomics as an authorized service provider for single-cell sequencing across Southern Europe.
Public source
Publisher name
Public post
🚀 Exciting News! Flomics is partnering with M20 Genomics! 🧬 We are thrilled to announce that Flomics has officially signed a collaboration agreement with M20 Genomics!…
Company
Flomics
Liquid biopsies with cell-free RNA. A revolutionary tool for diagnosis, prognosis and patient stratification.
- Industry
- Biotechnology Research
- Location
- Barcelona, ES
- Company size
- 11–50 employees
About Flomics
Flomics is developing novel blood-based diagnostic tools for a broad range of complex diseases. Our proprietary technology accurately identifies pattern changes in the circulating long RNA molecules of patients. With deep learning algorithms we identify RNA changes associated with disease states in a faster, cheaper and non-invasive way.
See moreDiscover more
Similar signals
Similar public activity from other companies.
Partnerships
M20 Genomics
M20 Genomics welcomed Flomics as an authorized service provider for the VITA Single-Cell Transcriptome Platform in Southern Europe.
Partnerships
Novogene Europe
Novogene Europe became a member of the Oxford Nanopore Technologies Service Provider Programme.
Partnerships
BioTuring
BioTuring announced a partnership with Qlucore to make giga-scale single-cell and multi-technology spatial data analysis faster, seamless, and code-free for researchers across the EU, UK, Switzerland, and Norway.
Partnerships
AD-Omics
AD-Omics is supporting the newly announced UK Pre-clinical Translational Models Hub as a technical partner.
Partnerships
Lexogen